TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression

by Ho, V, Lim, T.S, Lee, J, Steinberg, J, Szmyd, R, Tham, M, Yaligar, J, Kaldis, P, Abastado, J.-P, Chew, V
Published 2020

Unraveling the Inconsistencies of Cardiac Differentiation Efficiency Induced by the GSK3? Inhibitor CHIR99021 in Human Pluripotent Stem Cells

by Laco, F., Woo, T.L., Zhong, Q., Szmyd, R., Ting, S., Khan, F.J., Chai, C.L.L., Reuveny, S., Chen, A., Oh, S.
Published 2021